Use of il-i antibodies for treating ophthalmic disorders

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2648223

This invention relates to the use of compounts that disrupt IL-I receptor interaction for the treatment and/or prevention of ophthalmic diseases or disorders in mammals, particularly humans.

Cette invention porte sur l'utilisation de composés qui interrompent l'interaction du récepteur de l'interleukine-1 (IL-1) pour le traitement et/ou la prévention de maladies ou troubles ophtalmiques chez le mammifère, en particulier chez l'homme.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of il-i antibodies for treating ophthalmic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of il-i antibodies for treating ophthalmic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of il-i antibodies for treating ophthalmic disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1482728

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.